Myeloid Malignancy Flashcards
What are the Myeloid Malignancies?
Acute myeloid Leukaemia (AML)
Chronic Myeloid Leukaemia (CML)
Myelodysplastic syndromes (MDS)
Myeloproliferative neoplasms (MPN)
Pathology of AML
Leukemic cells do not differentiate
Bone marrow failure
Prognosis of AML
Rapidly fatal if untreated
Potentially curable
Subgroups of acute leukaemia
Acute myeloblastic leukaemia (AML)
Acute lymphoblastic leukaemia (ALL)
Presentation of Acute myeloblastic leukaemia
Bone marrow failure
- anaemia
- thrombocytopenic bleeding (purpura and mucosal)
- infection because of neutropenia (predominately bacterial and fungal)
Splenomegaly
Bone pain
Investigations of acute myeloblastic leukaemia
Blood count and blood film
Bone marrow aspirate / trephine
Cytogenetics (karyotype) from leukaemic blasts
Immunophenotyping of leukaemic blasts
CSF exam if symptoms
Targeted molecular genetics for associated gene mutations e.g. FLT3
Treatment of acute myeloblastic leukaemia
Supportive
Anti-leukaemic chemotherapy
- daunorubicin and cytosine arabinoside
Allogenic stem cell transplantation
All-trans retinoic acid (ATRA) and arsenic trioxide (ATO) in low risk acute promyelocytic anaemia
Targeted treatment - midostaurin in FLT3 mutated AML
Pathology of CML
Leukaemic cells retain ability to differentiate
Proliferation without bone marrow failure
Prognosis of CML
Survival for a few years historically
Long term survival / possible cures with modern therapy
Presentation of CML
Often no symptoms Low grade fever / sweating Malaise Anaemia Splenomegaly, often massive - left upper quadrant fullness / leading to abdominal discomfort Weight loss Hyperleukostasis - fundal haemorrhage and venous congestion - altered consciousness - resp failure Gout
CML blood features
High WCC (can be VERY high)
Low Hb
High Platelets or may be reduced due to big spleen
High neutrophils
Anaemia
Blood film shows all stages of white cell differentiation with increased basophils
Bone marrow hypercellular
Increased mature granulocytes (basophils, eosinophils, neutrophils) so there is no immunosuppression
High or low red cell count due to the big spleen
Decreased leukocyte alkaline phosphatase
Treatment of CML
Tyro kinase inhibitors (TKIs)
- Imatinib - 1st line
Allogenic transplantation (few now) only in TKI failures
Bone marrow transplant only possible cure
Hydroxyurea
Interferon alpha
What are myelodysplastic syndromes?
Acquired clonal disorders of the bone marrow
What age are myelodysplastic syndromes common?
Elderly
Presentation of myelodysplastic syndromes
Macrocytic anaemia
Pancytopenia
Neutropenia
Bone marrow often hypercellular but the cells are not released into the blood
What is myelodysplastic syndromes in relation to leukaemia?
Pre-leukaemic
Prognosis of myelodysplastic syndromes
Pre-leukaemic
Fatal as result of progression to bone marrow failure or AML
Treatment of myelodysplastic syndromes
Supportive
Stem cell transplantation for the few younger patients
Types of myeloproliferative neoplasms (MPN)
Polycythaemia Vera (PV) Essential thrombocythemia (ET) Idiopathic myelofibrosis (IM)
Mutations in myeloproliferative neoplasms
JAK2V617F mutation in > 98% of PV
PV in 50% of ET and myelofibrosis
CALR mutation in 25% of ET
Presentation of Polycythaemia Vera
Headaches Itch - intense - after exposure to hot water or hot and humid weather Vascular occlusion Thrombosis (e.g. DVT) TIA, stroke Splenomegaly 20% will suffer from gout
Lab features of polycythaemia vera
Elevated red cells
Elevated platelets in 50%
Raised Hb and haematocrit
Tendency to have raised WCC and platelet count
A raised uric acid
True increase in red cell mass when blood volume measured
Treatment of PV
Venesection to keep the haematocrit level below 0.45 in men and 0.43 in women
Aspirin
Hydroxcarbamide (HC)
Ruxolitnib (JAK2 inhibitor) in HC failures with systemic symptoms
Prognosis of PV
Stroke and other arterial or venous thromboses if poorly controlled
Bone marrow failure from development of secondary myelofibrosis
Transformation to AML
What is Essential thrombocythaemia (ET)?
Myeloproliferative disease with predominant feature of raised platelet count
Mutations of ET
50% +ve for JAK2V617F mutation
25% positive for calreticulin (CALR) mutuation
Presentation of ET
Symptoms of arterial and venous thrombosis Digital ischaemia Gout Headache Mild splenomegaly
Treatment of ET
Aspirin
Hydroxycarbamide or anagrelide
What can ET progress to?
Myelofibrosis
AML
What mutation causes > 98% of primary polycythaemia?
JAK2
Causes of haematological malignancy
Radiation Non therapeutic Chemo Smoking Chemicals e.g. benzene HIV HTLV1 and EBV Immunosuppressants Downs syndrome
Who is AML most common in?
Elderly
What is prognosis related to in AML?
Classification and cytogenic changes